Comment
doi: 10.1200/JCO.1989.7.10.1580.
Adverse interactions between cytotoxic drugs and hormonal agents in human breast cancer cells
- PMID: 2778487
- DOI: 10.1200/JCO.1989.7.10.1580
Item in Clipboard
Comment
Adverse interactions between cytotoxic drugs and hormonal agents in human breast cancer cells
J Clin Oncol.
1989 Oct.
No abstract available
Comment on
-
Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens.J Clin Oncol. 1989 Jun;7(6):710-7. doi: 10.1200/JCO.1989.7.6.710. J Clin Oncol. 1989. PMID: 2715802
Similar articles
-
Chemotherapy, oestrogens and hair loss.Br J Dermatol. 2014 Mar;170(3):493-4. doi: 10.1111/bjd.12891. Br J Dermatol. 2014. PMID: 24617428 No abstract available.
-
Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer.Neth J Med. 2009 Jun;67(6):245-6. Neth J Med. 2009. PMID: 19749398 No abstract available.
-
Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.Int J Oncol. 2005 Apr;26(4):1025-31. Int J Oncol. 2005. PMID: 15753998
-
Adjuvant treatment of breast cancer.R I Med. 1995 Sep;78(9):250-3. R I Med. 1995. PMID: 7579720 Review. No abstract available.
-
New drugs for breast cancer.Lancet. 2002 Sep 7;360(9335):790-2. doi: 10.1016/S0140-6736(02)09903-8. Lancet. 2002. PMID: 12241842 Review. No abstract available.
Cited by
-
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.Cancer Chemother Pharmacol. 1994;34(6):459-64. doi: 10.1007/BF00685655. Cancer Chemother Pharmacol. 1994. PMID: 7923555
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
